Growth Metrics

Incyte (INCY) Cost of Revenue (2016 - 2026)

Incyte filings provide 17 years of Cost of Revenue readings, the most recent being $104.5 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 42.81% to $104.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $403.5 million, a 24.41% increase, with the full-year FY2025 number at $372.1 million, up 19.25% from a year prior.
  • Cost of Revenue hit $104.5 million in Q1 2026 for Incyte, down from $121.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $121.2 million in Q4 2025 to a low of $42.6 million in Q1 2022.
  • Median Cost of Revenue over the past 5 years was $69.8 million (2023), compared with a mean of $73.6 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 45.84% in 2022 and later grew 2.78% in 2025.
  • Incyte's Cost of Revenue stood at $59.2 million in 2022, then rose by 17.9% to $69.8 million in 2023, then rose by 26.86% to $88.5 million in 2024, then soared by 36.94% to $121.2 million in 2025, then fell by 13.74% to $104.5 million in 2026.
  • The last three reported values for Cost of Revenue were $104.5 million (Q1 2026), $121.2 million (Q4 2025), and $99.0 million (Q3 2025) per Business Quant data.